He was last seen in clinic [**5-30**] w Dr. [**Last Name (STitle) 410**] for preadmission testing prior to planned admission today for a non-myeloablative matched unrelated donor transplant for his MDS that is associated with pancytopenia and transfusion dependence of both red cells and platelets.
Last transfusion [**5-28**].
Per Dr.[**Name (NI) 3588**] clinic evaluation on [**5-23**] this pt has an absolute neutropenia.
Past Medical History: Past Medical History: -CAD, s/p ant MI [**2139**], with hx LCX, LAD and RCA stenosis seen on cardiac CT 2/[**2164**].
- [**4-/2165**] EF 55%; cardiology cleared for transplant -Angina - once weekly depending on anemia and stress levels normally lasting 10-15 mins and resolves with nitro.
Hematologic Hx Longstanding history of myelodysplastic disorder associated with severe pancytopenia, now red cell and platelet transfusion requiring.
Alcohol -he has not had any ETOH in 2 weeks, typically drinks 2 drinks per week.
CN exam - II-XII normal, normal cerebellar function with FTS and HTS intact.
Pertinent Results: ADMISSION LABS =============== [**2165-6-3**] 09:05AM BLOOD WBC-1.3* RBC-2.90* Hgb-8.9* Hct-23.9* MCV-82 MCH-30.6 MCHC-37.3* RDW-13.1 Plt Ct-24*# [**2165-6-3**] 09:05AM BLOOD Neuts-15* Bands-0 Lymphs-75* Monos-7 Eos-0 Baso-0 Atyps-3* Metas-0 Myelos-0 [**2165-6-3**] 09:05AM BLOOD PT-12.0 PTT-25.4 INR(PT)-1.0 [**2165-6-3**] 09:05AM BLOOD UreaN-23* Creat-1.1 Na-139 K-4.6 Cl-103 HCO3-27 AnGap-14 [**2165-6-3**] 09:05AM BLOOD ALT-23 AST-18 LD(LDH)-131 AlkPhos-86 TotBili-0.8 DirBili-0.2 IndBili-0.6 [**2165-6-3**] 09:05AM BLOOD TotProt-7.2 Albumin-4.8 Globuln-2.4 Calcium-10.3 Phos-3.8 Mg-2.2 UricAcd-4.7  MICRO ===== - Multiple blood cultures (including mycolytic) and BAL cultures pending at the time of death.
IMAGES ====== Head CT [**2165-6-13**] NON-CONTRAST HEAD CT: There is no intracranial hemorrhage, parenchymal edema, or mass effect.
There is no CT evidence of territorial infarct.
Renal Ultrasound [**2165-6-13**] No hydronephrosis or other findings to explain acute renal failure.
CT chest [**2165-6-16**] 1.
Abdominal ultrasound [**2165-6-18**] 1.
MRI head w/o contrast [**2165-6-18**] 1.
CT Torso [**2165-6-22**] IMPRESSION: 1.
Echo [**2165-6-23**] Due to suboptimal technical quality, a focal wall motion abnormality cannot be fully excluded.
Overall left ventricular systolic function is severely depressed (LVEF= 20-25 %).
Compared to the findings of the prior study of [**2165-5-16**], left and right ventricular systolic function have deteriorated significantly.
His creatinine was 1.1 on admission and rose to > 5 following administration of clofarabine per SCT protocol.
At approximately 3:12 AM on [**2165-6-24**], housestaff were called to evaluate the patient after his nurse noticed his A-line pressure [**Location (un) 1131**] dropped abruptly to SBP in the 10s-20s.
Pulseless electrical activity was noted on the monitor at interval 2-minute pulse checks (no shockable rhythm).
The monitor continued to show pulseless electrical activity for several minutes with slowing heart rate until asystole.
Medications - OTC CHOLECALCIFEROL (VITAMIN D3) [VITAMIN D-3] 400 unit Tablet Daily CYANOCOBALAMIN (VITAMIN B-12) 1,000 mcg Tablet daily MULTIVITAMIN - 1 Tablet PYRIDOXINE - 100 mg daily Zyrtec 1 tab daily  Discharge Medications: Expired  Discharge Disposition: Expired  Discharge Diagnosis: Expired  Discharge Condition: Expired  Discharge Instructions: Expired  Followup Instructions: Expired   Completed by:[**2165-6-25**
